After a literature search for English publications, there is no systematic‐review‐based clinical practice guideline to date on these five basal insulin regimens for adult T2DM insulin‐naïve patients with inadequately controlled glucose (ie, glycated hemoglobin [HbA1c] > 7.0%) treated with one or more oral glucose‐lowering drugs in the Asian‐Pacific region. Here, INS is linked to type 2 diabetes mellitus.